Objectives: To investigate prospectively the independent predictors of a minimum clinically important change (MCIC) in quality of life (QOL) after anterior temporal lobectomy (ATL) for drug-resistant mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) in Brazilian patients. Methods: Multiple binary logistic regression analysis was performed to identify the clinical, demographic, radiologic, and electrophysiologic variables independently associated with MCIC in the Quality of Life in Epilepsy-31 Inventory (QOLIE-31) overall score 1 year after ATL in 77 consecutive patients with unilateral MTLE-HS. Results: The overall QOLIE-31 score and all its subscale scores increased significantly (p < 0.0001) 1 year after ATL. In the final logistic regression model, absence of presurgical diagnosis of depression (adjusted odds ratio [OR] 4.4, 95% confidence interval [CI] 1.1-16.1, p = 0.02) and a complete postoperative seizure control (adjusted OR 4.1, 95% CI 1.2-14.5, p = 0.03) were independently associated with improvement equal to or greater than the MCIC in QOL after ATL. The overall model accuracy for MCIC improvement in the QOL was 85.6%, with a 95.2% of sensitivity and 46.7% of specificity. Significance: These results in Brazilian patients reinforce the external validation of previous findings in Canadian patients showing that presurgical depression and complete seizure control after surgery are independent predictors for meaningful improvement in QOL after ATL, and have implications for the surgical management of MTLE patients.
remediable epilepsy syndrome. 6 Two randomized 6, 7 and several nonrandomized [8] [9] [10] studies showed that anterior temporal lobectomy (ATL) and mesial temporal lobectomy are safe and more effective to control epileptic seizures than additional pharmacologic treatments. However, in adults with drug-resistant epilepsies the adverse effects of antiepileptic drugs (AEDs) and depressive symptoms were better predictors of QOL than seizure frequency itself. 3, 5 Few studies have investigated factors that predict QOL after surgery using multivariate analyses, which are useful to identify variables that predict different clinical outcomes. 5, 11 Multivariate analysis may be particularly useful to predict QOL in patients with epilepsy, as these allow control for confounding variables that may be associated with the final scores of QOL instruments. 4, 5 The Quality of Life in Epilepsy Inventory-31 (QOLIE-31) has been validated to measure QOL of people with epilepsy (PWE) including those with drug-resistant MTLE-HS. 1, 5, 12 Previously we demonstrated that up to 36% of the QOLIE-31 overall score variance in drug-resistant patients with MTLE-HS who are candidates for epilepsy surgery is explained by a positive history of initial precipitant injury (IPI; occurrence of nonprolonged febrile convulsion and prolonged seizures with or without fewer, brain trauma, cerebral infection, cerebral hypoxia in the infancy), family history of epilepsy, disease duration, age at epilepsy onset, seizure frequency and presence of a psychiatric axis II diagnosis. 5 Twenty-three studies reviewed by Seiam et al. 13 and five additional studies reviewed by us analyzed QOL before and after epilepsy surgery. 6, 7, [14] [15] [16] These studies emphasize the positive impact of epilepsy surgery on QOL by comparing QOL grouped data without exploring clinically important change (CIC) for individual patients and how many individuals reach a CIC in QOL. The amount of change in the QOL instruments that a patient considers important is termed minimum clinically important change (MCIC). 17, 18 The MCIC allows for the categorization of individual patients in terms of reaching clinically meaningful changes in specific QOL questionnaires, and requires knowing the thresholds in specific QOL instrument scores that signify an MCIC. There is only one Canadian study using the MCIC concept to determine the effect of epilepsy surgery on QOL in temporal lobe epilepsy. 18 Here we investigated prospectively the clinical, demographic, radiologic, and electrophysiologic variables independently associated with an MCIC in the QOLIE-31 overall score and its domains 1 year after ATL in patients with unilateral MTLE-HS.
Methods

Patients and presurgical evaluation
Written informed consent was obtained from all patients. Seventy-seven consecutive adults with refractory MTLE-HS who underwent ATL were enrolled prospectively during their presurgical evaluation using a predetermined research protocol approved by our Research Ethics Committee (registration 365FR30969). The presurgical and postsurgical evaluations were done by the same team (neurologists, neurophysiologists, psychiatrists, neuropsychologists and nurses) at the Center for Epilepsy Surgery of Santa Catarina State (CEPESC) between October 2008 and March 2014. Refractoriness was defined as failure to respond to at least two AEDs in adequate trials, and seizures impairing awareness occurring at least once a month in the last 12 months. All patients had complete medical history, seizure semiology, neurologic examination, psychiatric and neuropsychological evaluation, interictal and ictal videoelectroencephalography (VEEG) analysis, and magnetic resonance imaging (MRI) results consistent with MTLE-HS. 5, [19] [20] [21] [22] [23] [24] None of the included patients underwent VEEG recording with semi-invasive or invasive electrodes.
The clinical picture consisted of complex partial seizures with epigastric, autonomic, or psychic auras; focal slowing, interictal spikes, and sharp waves over the anterior, inferior, and mesial temporal regions on interictal scalp EEG; and hippocampal atrophy on T1 and fluid-attenuated inversion recovery (FLAIR) and increased hippocampal signal on T2 MRI and FLAIR sequences. We also included patients without an aura, normal routine EEG studies, or bilateral interictal spikes who showed typical dyscognitive (partialcomplex) seizures and MRI findings. Histopathology was carried out in 48 patients and confirmed hippocampus sclerosis. We excluded patients with extrahippocampal lesions, focal motor or sensory abnormalities on physical examination, bilateral synchronous or extratemporal interictal spikes, and impaired neurodevelopment because such features put the diagnosis of MTLE-HS in doubt. 5, [19] [20] [21] [22] [23] [24] [25] The presurgical clinical and demographic characteristics analyzed were gender, age, age at epilepsy onset, duration of epilepsy, years of education, positive history for an initial precipitating injury, epilepsy duration until the presurgical evaluation, monthly frequency of seizures impairing awareness in the year before evaluation for surgery, number of AEDs used at the time of surgery, and side of mesial temporal abnormality.
Key Points
• Depression is highly prevalent in patients with drugresistant mesial temporal lobe epilepsy (MTLE)
• Quality of life (QOL) improves in the majority of patients with surgically treated MTLE
• Absence of presurgical diagnosis of depression and complete postoperative seizure control are independent predictors for meaningful improvement of QOL after MTLE-HS surgery in Brazilian patients VEEG recording (Bio-logic; System Corp) was performed using scalp electrodes according to the international 10/20 system associated with the temporal 10/10 system. Visual interictal analysis was assessed in a 1 h sleep sample (between 5:00 and 7:00 a.m.) and 1 h sample during wakefulness (between 8:00 and 10:00 a.m.) in the first, second, and third days of VEEG monitoring. Patients had at least one habitual seizure during VEEG investigation.
Before ATL, all patients were assessed by an experienced psychiatrist with expertise in psychiatric comorbidities associated with epilepsy (RG) as described previously. 5, 23, 24 The psychiatric interviewers were blinded to the QOLIE-31 scores and lasted about 90-120 min. All patients were interviewed first alone and thereafter along with the caregiver. Present (current) axis I disorders were diagnosed according to Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition -DSM-IV -Axis I Disorders, Clinical Version (SCID I). 26, 27 All diagnoses were categorized into three main groups: (1) Depressive disorders; (2) Anxiety disorders; and (3) Others. The latter include postictal psychosis, interictal psychosis as described by the International League Against Epilepsy (ILAE) Commission on Psychobiology, and dysthymia. 28 Axis II Personality Disorders (PDs) were classified according to the DSM-IV. 29 We also considered an epilepsy-specific PD termed Gastaut-Geschwind syndrome (GGS), 28 which was classified as "other personality disorders" into Axis II diagnosis of DSM-IV. Patients were allocated into the following major diagnostic groups: Axis I, 0 = no diagnosis; 1, anxiety disorders; 2, depressive disorders; 3, others. According to Axis II, the diagnosis of patients was defined as: 0, no diagnosis; 1, personality disorders or personality disorders traits.
Quality of life evaluation and determination of minimum clinically important change
QOL was assessed during the presurgical evaluation and 1 year after surgery using the Brazilian version of QOLIE-31 that shows good reliability, validity, and construct validity. 1, 5 Scores were determined according to the QOLIE-31 scoring manual. 30 Estimates of MCIC can be obtained using distributional (statistical) and patient-reported (clinical) methods. 18 Because we did not have patient-centered clinical estimates of changes we used a distribution-based statistical estimates. We calculated the difference between the post minus the pre surgical QOLIE-31 overall score and considered a change of 18 points as an MCIC after ATL in our patients. This value is equivalent to one standard deviation (SD) from the mean presurgical QOLIE-31 overall score in our patients and corresponds to a medium improvement of QOL change based on Wiebe et al. 17, 18 The 18-point cutoff excludes the chance or measurement error in our surgical candidates with >95% certainty. This cutoff point is similar to that previously reported by Wiebe et al. 31 in medically refractory TLE. The same approach was also applied to determine the MCIC for each of the seven domains of the QOLIE-31 questionnaire.
Surgical procedure and routine postsurgical follow up Epilepsy surgery was done at CEPESC (neurosurgeon MNL, n = 53) or University Hospital (neurosurgeon CG, N = 24) as described previously. 20, 32 Both neurosurgeons applied similar surgical procedures. The temporal lobe resection included the middle and inferior temporal gyri extended up to 4 cm posterior from the temporal pole. After assessing the mesial temporal region, at least two thirds of the amygdala was resected including its basal and the lateral nucleus. After the amygdala resection, the hippocampus was removed "en bloc." Routine neurologic and neurosurgical follow-up and seizure outcome evaluation was done by two experienced epileptologists (RW or KL) and the neurosurgery team 1, 3, 6, and 12 months after surgery. Maintenance of AED treatment after surgery in the same schedule as before surgery was strongly reinforced to all patients and their caregivers.
Statistical analysis
Differences between presurgical and postsurgical QOLIE-31 overall score and its subtests scores were analyzed by paired t-test. Univariate binary logistic regression was used to investigate the clinical, demographic, radiologic, electrophysiologic, presurgical QOLIE-31, and psychiatric diagnoses associated with QOL improvement in the QOLIE-31 and its domains after surgery based on our adopted MCIC criteria. For the analysis, the continuous variables were categorized based on the clinical experience and biologic plausibility for analysis. The magnitude of association between QOL improvement and the independent variables was measured by the crude odds ratio (OR) and respective 95% confidence interval (95% CI).
Multiple binary logistic regression was used to identify the variables independently associated with QOL improvement 1 year after the ATL. For this analysis, only variables showing an association with QOL improvement for a p level <0.15 in the univariate analysis were included. Because the QOL does not differ between patients with auras only or those with seizures impairing consciousness (p > 0.08), seizure outcome was dichotomized as seizure-free or seizures (auras or seizures with impairing consciousness). Because depression was the only psychiatric diagnosis significantly associated with QOL change after ATL, for the final regression analysis, the psychiatric diagnosis was dichotomized according to the presence or absence of depression. The magnitude of association between QOL improvement and the independent variables was measured by the adjusted OR and the respective 95% CI. We determined the overall accuracy, specificity, and sensitivity for the final model of binary regression to predict the MCIC for a QOL improvement. A p level < 0.05 was considered statistically significant. The 
Results
No patient showed psychosis, depression, anxiety, or a personality disorder that contraindicated surgical procedures or could impair the postsurgical follow-up and treatment. Family support was adequate in all cases.
Transient surgical complications comprised transient right hemiparesis and language disturbance in two patients, related to significant left brain hemisphere edema after surgery, with full recovery in <1 week. One patient had a skin infection of the surgical wound, successfully treated with antibiotics. One patient had skull osteomyelitis after surgery, successfully treated with antibiotics and cranioplasty. Visual field deficits were not objectively tested in follow-up and also were not reported by patients. No irreversible surgical complication was reported. The AEDs used in mono or in combined polytherapy were phenytoin (n = 10), oxcarbazepine (n = 10), carbamazepine (n = 58), phenobarbital (n = 24), lamotrigine (n = 8), topiramate (n = 8), or valproate (n = 17). The benzodiazepines used as adjunctive therapy were clobazam or clonazepam (n = 39).
One year after ATL, 49 patients (63.6%) remained completely seizure-free; six patients (7.8%) had auras only; 14 patients (18.2%) had up to two seizures impairing awareness, and 8 (10.4%) patients had more than two seizures impairing awareness (Engel class III or IV). Among the patients with up to two seizures impairing awareness, seven (9%) had a single seizure in the first 60 days after surgery (perioperative seizures); one patient (1.3%) had a cluster of three seizures at 5 days after AED discontinuation (Engle class ID), and six patients (7.8%) had two spontaneous seizures after the perioperative period (Engel class II). Figure 1 shows mean (SE) presurgical and postsurgical overall QOLIE-31 scores and its subtest scores. There was a significant improvement of all the mean QOLIE-31 domains evaluated 1 year after ATL (p < 0.0001). Table 1 shows the proportion of patients achieving various levels of change in QOLIE-31 overall score 1 year after ATL. None of the patients had a significant decline (1 SD) in the QOLIE-31 overall score after the ATL. Eighty-nine percent reached the criteria for MCIC and 80.5% and 58.4% had medium (1 SD) and large (1.33 SD) changes in their QOLIE-31 overall scores, respectively. MCIC according to the QOLIE-31 subdomains are also described in Table 1 . Table 2 shows the results of univariate binary logistic regression analyses for predictors of QOL improvement after ATL. There was a trend for association between QOL improvement and right-sided surgery (p = 0.09) and higher levels of education (p = 0.08). A significant QOL improvement was observed in patients without a diagnosis of depression in the presurgical evaluation (p = 0.004) and among patients that became seizure-free (no auras and no seizures impairing awareness) after surgery (p = 0.01). The same analysis was also done to identify the variables associated with an MCIC improvement in each QOLIE-31 subdomain (data not shown). Table 3 shows the multiple regression analyses for the variables independently associated with MCIC after ATL. Model 1 included only presurgical variables. Model 2 included the seizure control after surgery and the presurgical variables. Among the presurgical determinants of QOL improvement, only the absence of presurgical depression remains significantly associated with QOL improvement (adjusted OR 5.3, 95% CI 1.6-17.7, p = 0.007). In comparison to left-side surgery, there was a trend for QOL improvement among patients who underwent right ATL (adjusted OR 2.7, 95% CI 0.8-9.6, p = 0.10). Model 1 including the diagnosis of depression and side of surgery shows an 80.5% overall accuracy, with null specificity and 100% of sensitivity for the MCIC improvement in the QOLIE-31 overall score. Model 2 (Table 2) shows that absence of presurgical depression (adjusted OR 4.4, 95% CI 1.1-16.1, p = 0.02) and absence of any seizure type (adjusted OR 4.1, 95% CI 1.2-14.5, p = 0.03) after surgery remain independently associated with MCIC of QOLIE-31 overall score, showing an overall accuracy of 85.7%, with 46.7% of specificity and 95.2% of sensitivity. None of the presurgical variables were predictors of the QOLIE-31 subdomains: Seizure Worry, Overall QOL, and Energy and Fatigue. Overall QOL and Energy and Fatigue also were not associated with the seizure control after surgery. An MCIC improvement in Emotional Well-Being, Cognitive Function, Medication Effects, and Social Function showed a variable degree of association with no presurgical depression, right side of surgery, education level, and social function (see Model 1 and Model 2 results in the Table 3 ).
Discussion
We found a significant improvement in the QOL of our patients with drug-resistant MTLE-HS 1 year after ATL. The results are in agreement with several previous controlled and noncontrolled studies using the QOLIE-31 or other instruments including the Quality of Life in Epilepsy Inventory-89 (QOLIE-89), the Epilepsy Surgery Inventory-55 (ESI 55), the Washington, Psychosocial Seizure Inventory (WPSI), and the Short-Form Health Survey (SF-36).
6,9,10,13-16,33, 34 We also replicated a recent Canadian study showing the improvement of QOL after ATL based on the MCIC criteria established for their patients. 18 Using the MCIC criteria applied in the Canadian study, none of our patients worsened and 89.6% of them improved in QOL scores 1 year after ATL. In the Canadian study, 8% worsened and 62% achieved the MCIC 6 months after surgery.
Presurgical psychiatric diagnosis or impaired psychological function has been reported to be associated with lower mean QOL after ATL by other authors. 15, [35] [36] [37] In our patients, among all the investigated variables, after the multiple regression analysis, the absence of depression in the presurgical evaluation and a complete seizure control after surgery remain associated with MCIC in the QOL 1 year after the ATL. The impact of psychiatric treatment before ATL on postsurgical Health Related Quality of Life (HRQOL) is an important point that deserves to be investigated.
In our patients, the side of surgery showed a trend for association with a QOL after ATL, with better prognosis after right-sided surgery. A trend for association between the laterality of surgery and QOL evaluated by the ESI 55 questionnaire was also reported after ATL in Brazilian, 15 Portuguese, 33 and German 38 patients. A large prospective, multicentric study including 325 (87.1%) temporal lobe resections and 48 (12.9%) extratemporal resections also showed a trend (p = 0.09) for negative association between surgery performed in the left side of the brain and QOL up to 5 years after the epilepsy surgery. 10 When the subdomain cognitive function is analyzed, the right side of surgery remains strongly associated with an MCIC. We believe the Changes of 1 SD (equivalent of 18 points) of the presurgical QOLIE-31 overall score were considered an MCIC of QOL improvement. AED, antiepileptic drug. a One widhover patient was classified as a divorced. b Other diagnosis: Postictal psychosis (n = 2), pharmacologically well treated interictal psychosis (n = 2); dysthymia (n = 2).
observed trend of association between side of surgery and QOL after ATL is more dependent on the impact of surgery on perception of cognitive performance by the patient. The association between the patient perception of decline in his cognitive domain of QOLIE-31 with the right-sided surgery and the objective neuropsychological impairment remains to be demonstrated. Freedom of auras has been found to be essential for continuing improvement of QOL after the first 2 years after surgery, 8, 38, 39 whereas in a study by Langfitt et al., patients with or without auras showed similar gains in QOL measured by QOLIE-31 after surgery. The same authors showed that QOL improves or remains stable in seizure-free patients despite memory decline, but QOL declines when persistent seizures are accompanied by memory decline. The presence of psychiatric disorders after epilepsy surgery also has been be associated with poor QOL. 13 The severity of postoperative depression and anxiety affects negatively the QOL gains after epilepsy surgery. 12 The power of cognitive decline and the presence of psychiatric diagnosis after ATL to predict an MCIC in QOL after surgery deserves further investigation.
Of interest, when the QOLIE-31 domains are analyzed independently, none of the investigated variables remain associated with an MCIC improvement of seizure worry, overall QOL, and energy and fatigue, except the meaningful improvement of seizure worry that was associated with absence of seizures after surgery. Identification of predictors of MCIC for these QOLIE-31 domains may help to improve the accuracy of the final predictive model of MCIC of QOLIE-31 overall score. The absence of presurgical depression and complete seizure control after surgery disclose a clinical and biologic plausibility for their association with emotional well-being. To our surprise, the medication effects were associated with the right-sided surgery but not with the polytherapy treatment. We believe that the influence of high levels of AEDs used in monotherapy or polytherapy had a similar impact on the QOL perception in our patients. The trend of positive association between the level of education and better outcome in the social function observed is also plausible, but this association also may be at least in part due to confounding bias related to a higher socioeconomic level among people with higher education level. We also speculate that right temporal lobe epilepsy had a lower impact on cognitive performance and that this could contribute with a social function improvement.
The strengths of our study include its prospective longitudinal design, the absence of cases missing for follow-up, the multivariate analysis, and the methodology applied to evaluate the QOL changes after the epilepsy surgery. There are, of course, also limitations. The lack of a control group and a randomized controlled design do not permit exclusion of the placebo effect and the response shift phenomena 40 affecting the longitudinal changes in QOLIE-31 after surgery. The relatively short time of follow-up, considering the QOL improvement may continue for more than 12 months in seizure-free patients as well in those showing seizure relapse during long-term follow-up. The relatively small sample size hinders the identification of variables with a discrete effect on QOL to detect an MCIC for the QOLIE-31 overall score and for its subdomains.
These results in Brazilian patients reinforce the external validation of previous findings in Canadian patients showing that presurgical depression and complete seizure control after surgery are independent predictors for meaningful improvement in QOL after ATL, and have implications for the surgical management of MTLE patients.
